Park Square has placed Beth Marsh as Chief Commercial Officer at Neurotech Pharmaceuticals.
| less than a minute read
Neurotech Appoints Beth Marsh as Chief Commercial Officer
Neurotech Pharmaceuticals, Inc., a private biotech company focused on developing transformative therapies for chronic eye diseases, announced the appointment of Beth Marsh as Chief Commercial Officer, effective April 28, 2025.

/Passle/58a5cb8db00e8110e83aa395/MediaLibrary/Images/2026-11-19-15-40-01-479-6aff1851ff5130799d088a3b.png)
/Passle/58a5cb8db00e8110e83aa395/MediaLibrary/Images/2026-11-06-17-39-37-187-6aee10d9e051d7ffd7756b19.jpeg)
/Passle/58a5cb8db00e8110e83aa395/MediaLibrary/Images/2026-09-29-16-59-13-899-6abbee61460fb9469a25b973.jpg)